BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15978681)

  • 1. Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase.
    Pang CK; De SK; White J; Buckner FS; Varani G; Rathod PK
    Mol Biochem Parasitol; 2005 Sep; 143(1):121-4. PubMed ID: 15978681
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
    Mudeppa DG; Pang CK; Tsuboi T; Endo Y; Buckner FS; Varani G; Rathod PK
    Mol Biochem Parasitol; 2007 Feb; 151(2):216-9. PubMed ID: 17157934
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694.
    Hekmat-Nejad M; Rathod PK
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1628-32. PubMed ID: 8807052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prized malaria drug target nailed.
    Rathod PK; Phillips MA
    Nat Struct Biol; 2003 May; 10(5):316-8. PubMed ID: 12714998
    [No Abstract]   [Full Text] [Related]  

  • 5. Subunit complementation of thymidylate synthase in Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase.
    Chanama M; Chitnumsub P; Yuthavong Y
    Mol Biochem Parasitol; 2005 Jan; 139(1):83-90. PubMed ID: 15610822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
    J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization, heterologous expression and kinetic analysis of recombinant Plasmodium falciparum thymidylate kinase.
    Kandeel M; Kitade Y
    J Biochem; 2008 Aug; 144(2):245-50. PubMed ID: 18477629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO.
    Dufe VT; Qiu W; Müller IB; Hui R; Walter RD; Al-Karadaghi S
    J Mol Biol; 2007 Oct; 373(1):167-77. PubMed ID: 17822713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
    de Beer TA; Louw AI; Joubert F
    Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in biochemical properties of the Plasmodial falcipain-2 and berghepain-2 orthologues: implications for in vivo screens of inhibitors.
    Chan C; Goh LL; Sim TS
    FEMS Microbiol Lett; 2005 Aug; 249(2):315-21. PubMed ID: 16019160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
    Ionita M; Krishna S; Léo PM; Morin C; Patel AP
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.
    Doan LT; Martucci WE; Vargo MA; Atreya CE; Anderson KS
    Biochemistry; 2007 Jul; 46(28):8379-91. PubMed ID: 17580969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of FK506 binding domain (FKBD) of Plasmodium falciparum FK506 binding protein 35 (PfFKBP35).
    Kang CB; Ye H; Yoon HR; Yoon HS
    Proteins; 2008 Jan; 70(1):300-2. PubMed ID: 17876830
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemistry. DNA building block reinvented.
    Murzin AG
    Science; 2002 Jul; 297(5578):61-2. PubMed ID: 12029066
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural basis for parasite-specific functions of the divergent profilin of Plasmodium falciparum.
    Kursula I; Kursula P; Ganter M; Panjikar S; Matuschewski K; Schüler H
    Structure; 2008 Nov; 16(11):1638-48. PubMed ID: 19000816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase.
    Tokuoka K; Kusakari Y; Krungkrai SR; Matsumura H; Kai Y; Krungkrai J; Horii T; Inoue T
    J Biochem; 2008 Jan; 143(1):69-78. PubMed ID: 17981823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and mechanistic insights into the action of Plasmodium falciparum spermidine synthase.
    Burger PB; Birkholtz LM; Joubert F; Haider N; Walter RD; Louw AI
    Bioorg Med Chem; 2007 Feb; 15(4):1628-37. PubMed ID: 17196392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506.
    Kotaka M; Ye H; Alag R; Hu G; Bozdech Z; Preiser PR; Yoon HS; Lescar J
    Biochemistry; 2008 Jun; 47(22):5951-61. PubMed ID: 18465874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.